Enterprise Value
31.46M
Cash
16.83M
Avg Qtr Burn
-2.87M
Short % of Float
0.44%
Insider Ownership
5.58%
Institutional Own.
22.98%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Triferic® AVNU (ferric pyrophosphate citrate) Details Chronic kidney disease, Psoriasis, Kidney disease | Approved Quarterly sales | |
Triferic (ferric pyrophosphate citrate) Details Anemia (hemodialysis dependent chronic kidney disease) | Approved Quarterly sales |